Follow
Abraham H. Abouzeid
Abraham H. Abouzeid
Verified email at nist.gov
Title
Cited by
Cited by
Year
Nanopreparations to overcome multidrug resistance in cancer
NR Patel, BS Pattni, AH Abouzeid, VP Torchilin
Advanced drug delivery reviews 65 (13-14), 1748-1762, 2013
3562013
The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors
C Sarisozen, AH Abouzeid, VP Torchilin
European Journal of Pharmaceutics and Biopharmaceutics 88 (2), 539-550, 2014
1622014
Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer
AH Abouzeid, NR Patel, VP Torchilin
International journal of pharmaceutics 464 (1-2), 178-184, 2014
1332014
Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells
AH Abouzeid, NR Patel, C Sarisozen, VP Torchilin
Pharmaceutical research 31, 1938-1945, 2014
672014
Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin
AH Abouzeid, NR Patel, IM Rachman, S Senn, VP Torchilin
Journal of drug targeting 21 (10), 994-1000, 2013
652013
Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities
SP Berasi, U Varadarajan, J Archambault, M Cain, TA Souza, A Abouzeid, ...
Growth factors 29 (4), 128-139, 2011
602011
Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems
NR Patel, B Aryasomayajula, AH Abouzeid, VP Torchilin
Therapeutic delivery 6 (4), 509-520, 2015
452015
The role of cell cycle in the efficiency and activity of cancer nanomedicines
AH Abouzeid, VP Torchilin
Expert Opinion on Drug Delivery 10 (6), 775-786, 2013
272013
Intra-and trans-cellular delivery of enzymes by direct conjugation with non-multivalent anti-ICAM molecules
R Ghaffarian, N Roki, A Abouzeid, W Vreeland, S Muro
Journal of Controlled Release 238, 221-230, 2016
102016
In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications
D Gangaiah, SP Mane, NR Tawari, N Lakshmanan, V Ryan, A Volland, ...
Plos one 17 (1), e0262663, 2022
62022
Surface-modified micellar formulations of curcumin co-loaded with chemotherapeutic agents for enhanced anti-cancer effect
AH Abouzeid
Northeastern University, 2013
32013
ICAM-1 targeting by direct conjugation enhances gastrointestinal transcytosis and encapsulation enables gastric protection and controlled released for oral enzyme delivery
R Ghaffarian, H Oh, A Abouzeidc, W Vreelandc, S Raghavan, S Muro
Molecular Genetics and Metabolism 2 (117), S49, 2016
12016
Endocytosis of monomeric ICAM-1 targeting moieties provides intracellular transport of active enzyme conjugates
WN Vreeland, AH Abouzeid, S Muro, R Ghaffarian
Wyatt N. Vreeland, Abraham H. Abouzeid, Silvia Muro, Rasa Ghaffarian 238 …, 2016
2016
Nanotechnology-based treatment for chemotherapy-resistant breast cancer
AH Abouzeid, NR Patel, IM Rachman, S Senn, VP Torchilin
Biosensing and Nanomedicine VII 9166, 31-38, 2014
2014
Polyethylene Glycol–Phosphatidylethanolamine (PEG–PE)/Vitamin E Based Micelles for the Co-Delivery of Paclitaxel and Curcumin to Overcome Multi-Drug Resistance in Cancer
A Abouzeid, V Torchilin
3D Cancer Cell Spheroids as a Model For Investigating Co-Delivery of Paclitaxel and Curcumin by Targeted Mixed Micelles
C Sarisozen, AH Abouzeid, NR Patel, F Perche, VP Torchilin
The system can't perform the operation now. Try again later.
Articles 1–16